Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial

Eur J Heart Fail. 2024 Apr 17. doi: 10.1002/ejhf.3240. Online ahead of print.
No abstract available

Grants and funding